Both in Pharmaceuticals
Canopy Growth vs Prelude Therapeutics Incorporated
Over the past year CGC returned −41.1% and PRLD returned −5.0%; their daily moves had a correlation of 0.15.
CGC −41.1% PRLD −5.0%Growth of $1, one year, split-adjusted
| Metric | CGC | PRLD |
|---|---|---|
| Price | $0.7067 | $3.78 |
| Market cap | $299.0M | $301.7M |
| Today | +3.80% | −1.56% |
| 1 month | −20.1% | +0.3% |
| 6 months | −34.6% | −19.1% |
| Year to date | −38.0% | +30.3% |
| 1 year | −43.0% | +137.7% |
| Revenue growth (YoY) | +7.8% | — |
| Gross margin | 27.4% | 100.0% |
| Net margin | −18.0% | −244.1% |
| P/E (TTM) | — | — |
| Price / sales | 1.2× | 13.5× |
| Net cash | $67.9M | $151.8M |
| Dividend yield | — | — |
| Volatility (60d) | 41.8% | 74.7% |
| Short % of float | 7.5% | 13.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).